87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

byUniversity of Texas MD Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that imp

Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

byUniversity of Texas MD Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that imp
Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform

Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform
Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows

Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows

by Huntsman Cancer Institute at the University of UtahCredit: Artem Podrez from PexelsA Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Canc

Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows

by Huntsman Cancer Institute at the University of UtahCredit: Artem Podrez from PexelsA Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Canc
New theranostic approach effectively detects and treats neuroendocrine prostate cancer

New theranostic approach effectively detects and treats neuroendocrine prostate cancer

by Society of Nuclear Medicine and Molecular ImagingRET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding pe

New theranostic approach effectively detects and treats neuroendocrine prostate cancer

by Society of Nuclear Medicine and Molecular ImagingRET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding pe
RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

byDana-Farber Cancer InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA shift in the way people think about and treat pancreatic canc

RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

byDana-Farber Cancer InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA shift in the way people think about and treat pancreatic canc
FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainThe ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is a

FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainThe ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is a
Strongest evidence yet that vaping likely causes cancer

Strongest evidence yet that vaping likely causes cancer

by Bernard Stewart,The ConversationCredit: Unsplash/CC0 Public DomainAs early as the 1880s,there was evidencethat smoking tobacco damaged your lungs. But it took almost 100 years todefinitively showth

Strongest evidence yet that vaping likely causes cancer

by Bernard Stewart,The ConversationCredit: Unsplash/CC0 Public DomainAs early as the 1880s,there was evidencethat smoking tobacco damaged your lungs. But it took almost 100 years todefinitively showth
Targeted screening blitz could bring Indigenous cervical cancer elimination to 2036

Targeted screening blitz could bring Indigenous cervical cancer elimination to 2036

byAustralian National UniversityPredicted cervical cancer incidence (age standardized, per 100,000 females) between 2020 and 2100. Credit:The Lancet Public Health(2026). DOI: 10.1016/s2468-2667(26)000

Targeted screening blitz could bring Indigenous cervical cancer elimination to 2036

byAustralian National UniversityPredicted cervical cancer incidence (age standardized, per 100,000 females) between 2020 and 2100. Credit:The Lancet Public Health(2026). DOI: 10.1016/s2468-2667(26)000
Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

byMass General BrighamCredit: Unsplash/CC0 Public DomainIn some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical stu

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

byMass General BrighamCredit: Unsplash/CC0 Public DomainIn some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical stu
First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche

First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche
Breast cancer hijacks the lung repair system to fuel tumor growth, study finds

Breast cancer hijacks the lung repair system to fuel tumor growth, study finds

byUniversity of Colorado AnschutzResearchers at the CU Anschutz Cancer Center have discovered how breast cancer cells that spread to the lungs may take advantage of the body's natural healing resp

Breast cancer hijacks the lung repair system to fuel tumor growth, study finds

byUniversity of Colorado AnschutzResearchers at the CU Anschutz Cancer Center have discovered how breast cancer cells that spread to the lungs may take advantage of the body's natural healing resp
Cancer risk rises with autoimmune disorders but drops after anti-inflammatory therapy, finds study

Cancer risk rises with autoimmune disorders but drops after anti-inflammatory therapy, finds study

by Sbarro Health Research Organization (SHRO)Credit: Pixabay/CC0 Public DomainWhen patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and

Cancer risk rises with autoimmune disorders but drops after anti-inflammatory therapy, finds study

by Sbarro Health Research Organization (SHRO)Credit: Pixabay/CC0 Public DomainWhen patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and